Today news
About the same in other media
Yes, DeepMind crunches the numbers – but is it really a magic bullet?
Reading now: 863
The most interesting development of the week had nothing to do with Facebook or even Google losing its appeal against a €2.4bn fine from the European commission for abusing its monopoly of search to the detriment of competitors to its shopping service. The bigger deal was that DeepMind, a London-based offshoot of Google (or, to be precise, its holding company, Alphabet) was moving into the pharmaceutical business via a new company called Isomorphic Labs, the goal of which is grandly described as “reimagining the entire drug discovery process from first principles with an AI-first approach”.
Since they’re interested in first principles, let us first clarify that reference to AI. What it means in this context is not anything that is
Read more on theguardian.comAbout this in other media
Couple arrested in Netherlands after escaping COVID hotel quarantine euronews.com /3 years ago
'Lord of the Rings'-themed cryptocurrency blocked by JRR Tolkien estate moneycontrol.com /3 years ago
Indian crypto investors press the sell button economictimes.indiatimes.com /3 years ago
Show more
The website finance-news.co is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
